Deconstructing GSK‐3: The Fine Regulation of Its Activity

Miguel Medina, Francisco Wandosell(Biomedical Research Networking Center on Neurodegenerative Diseases)

International Journal of Alzheimer s Disease

January 1, 2011

10.4061/2011/479249

Cited by 160

Related Papers

Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies

|Frontiers in Molecular Neuroscience|2011|115

Cancer Stem Cell-Like Phenotype and Survival Are Coordinately Regulated by Akt/FoxO/Bim Pathway

|Stem Cells|2014|84

Clearance of β‐amyloid mediated by autophagy is enhanced by <scp>MTORC1</scp> inhibition but not <scp>AMPK</scp> activation in <scp>APP</scp>/<scp>PSEN1</scp> astrocytes

|Glia|2023|15